439 related articles for article (PubMed ID: 20564355)
21. Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection.
Kagawa T; Koizumi J; Kojima S; Nagata N; Numata M; Watanabe N; Watanabe T; Mine T;
Cancer; 2010 Aug; 116(15):3638-44. PubMed ID: 20564097
[TBL] [Abstract][Full Text] [Related]
22. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
Lubienski A; Bitsch RG; Schemmer P; Grenacher L; Düx M; Kauffmann GW
Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291
[TBL] [Abstract][Full Text] [Related]
23. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
[TBL] [Abstract][Full Text] [Related]
24. Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review.
Jansen MC; van Hillegersberg R; Chamuleau RA; van Delden OM; Gouma DJ; van Gulik TM
Eur J Surg Oncol; 2005 May; 31(4):331-47. PubMed ID: 15837037
[TBL] [Abstract][Full Text] [Related]
25. A critical appraisal of the literature on local ablative therapies for hepatocellular carcinoma.
Lencioni R; Crocetti L
Clin Liver Dis; 2005 May; 9(2):301-14, viii. PubMed ID: 15831275
[TBL] [Abstract][Full Text] [Related]
26. [Effectiveness of radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma].
Gao HJ; Liang HH; Chen MS; Peng ZW; Zhang YJ; Li P; Pang XH; Zhang YQ; Li JQ
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(36):2529-32. PubMed ID: 19080642
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial.
Akamatsu M; Yoshida H; Obi S; Sato S; Koike Y; Fujishima T; Tateishi R; Imamura M; Hamamura K; Teratani T; Shiina S; Ishikawa T; Omata M
Liver Int; 2004 Dec; 24(6):625-9. PubMed ID: 15566514
[TBL] [Abstract][Full Text] [Related]
28. [Comparison of radiofrequency ablation and transarterial chemoembolization for the treatment of a single hepatocellular carcinoma smaller than 4 cm].
Yang MJ; An SY; Moon EJ; Lee MS; Hwang JA; Cheong JY; Won JH; Kim JK; Wang HJ; Cho SW
Korean J Hepatol; 2009 Dec; 15(4):474-85. PubMed ID: 20037266
[TBL] [Abstract][Full Text] [Related]
29. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.
Yamagiwa K; Shiraki K; Yamakado K; Mizuno S; Hori T; Yagi S; Hamada T; Iida T; Nakamura I; Fujii K; Usui M; Isaji S; Ito K; Tagawa S; Takeda K; Yokoi H; Noguchi T
J Gastroenterol Hepatol; 2008 Mar; 23(3):482-90. PubMed ID: 18086115
[TBL] [Abstract][Full Text] [Related]
30. Percutaneous ablation of hepatocellular carcinoma: state-of-the-art.
Lencioni R; Cioni D; Crocetti L; Bartolozzi C
Liver Transpl; 2004 Feb; 10(2 Suppl 1):S91-7. PubMed ID: 14762847
[TBL] [Abstract][Full Text] [Related]
31. Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study.
El-Serag HB; Siegel AB; Davila JA; Shaib YH; Cayton-Woody M; McBride R; McGlynn KA
J Hepatol; 2006 Jan; 44(1):158-66. PubMed ID: 16290309
[TBL] [Abstract][Full Text] [Related]
32. Novel advancements in the management of hepatocellular carcinoma in 2008.
Llovet JM; Bruix J
J Hepatol; 2008; 48 Suppl 1():S20-37. PubMed ID: 18304676
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive sequential interventional therapy for hepatocellular carcinoma.
Zhang L; Fan WJ; Huang JH; Li CX; Zhao M; Wang LG; Tang T
Chin Med J (Engl); 2009 Oct; 122(19):2292-8. PubMed ID: 20079128
[TBL] [Abstract][Full Text] [Related]
34. Multidisciplinary treatment of patients with hepatocellular carcinoma.
Masaki T; Morishita A; Kurokohchi K; Kuriyama S
Expert Rev Anticancer Ther; 2006 Oct; 6(10):1377-84. PubMed ID: 17069523
[TBL] [Abstract][Full Text] [Related]
35. Treatment of hepatocellular carcinoma.
Blum HE
Best Pract Res Clin Gastroenterol; 2005 Feb; 19(1):129-45. PubMed ID: 15757809
[TBL] [Abstract][Full Text] [Related]
36. [Current therapeutic strategies for hepatocellular carcinoma, 2].
Wallner I; Hartmann H; Ramadori G
Leber Magen Darm; 1994 Sep; 24(5):187-201. PubMed ID: 7968178
[TBL] [Abstract][Full Text] [Related]
37. [Quality of life of primary hepatocellular carcinoma patients after radiofrequency ablation].
Wang YB; Chen MH; Yan K; Yang W; Dai Y; Yin SS
Ai Zheng; 2005 Jul; 24(7):827-33. PubMed ID: 16004809
[TBL] [Abstract][Full Text] [Related]
38. Combination therapy with radiofrequency ablation and transcatheter chemoembolization for the treatment of hepatocellular carcinoma: Short-term recurrences and survival.
Yamakado K; Nakatsuka A; Akeboshi M; Shiraki K; Nakano T; Takeda K
Oncol Rep; 2004 Jan; 11(1):105-9. PubMed ID: 14654911
[TBL] [Abstract][Full Text] [Related]
39. Radiofrequency ablation and chemoembolization for hepatocellular carcinoma.
Georgiades CS; Hong K; Geschwind JF
Cancer J; 2008; 14(2):117-22. PubMed ID: 18391617
[TBL] [Abstract][Full Text] [Related]
40. [Radiofrequency ablation combined with transcatheter arterial chemoembolization for the local recurrent tumor after resection of the adrenal metastasis from hepatocellular carcinoma--a case report].
Yasumoto T; Hayashi S; Shimizu J; Dono K; Nakata S; Sato M; Kitada M; Shimano T
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2371-3. PubMed ID: 20037426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]